Association between in Utero arsenic exposure, placental gene expression, and infant birth weight: A US birth cohort study

Environmental Health: A Global Access Science Source

Volumn 12, Issue 1, 2013, Pages

  Fei, Dennis Liang ^a,b,d   Koestler, Devin C ^b   Li, Zhigang ^b   Giambelli, Camilla ^a   Sanchez Mejias, Avencia ^a   Gosse, Julie A ^c   Marsit, Carmen J ^b   Karagas, Margaret R ^b   Robbins, David J ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b DARTMOUTH MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF MAINE   (United States)

^d NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

Author keywords

AQP9; Arsenic; Biomarker; Birth weight; ENPP2; Placenta

Indexed keywords

ARSENIC; PHOSPHOLIPASE; ALKYLGLYCEROPHOSPHOETHANOLAMINE PHOSPHODIESTERASE; AQP9 PROTEIN, HUMAN; AQUAPORIN; BIOLOGICAL MARKER; PHOSPHODIESTERASE; WATER POLLUTANT;

ARSENIC; BIOMARKER; COHORT ANALYSIS; EPIDEMIOLOGY; GENE EXPRESSION; POLLUTION EXPOSURE; PREGNANCY; WEIGHT; WOMENS HEALTH;

ADULT; ARTICLE; BIOPSY TECHNIQUE; BIRTH WEIGHT; COHORT ANALYSIS; DISEASE PREDISPOSITION; FEMALE; GENE EXPRESSION; HUMAN; MAJOR CLINICAL STUDY; NUCLEOTIDE SEQUENCE; PLACENTA; PLACENTA BIOPSY; PREGNANT WOMAN; PRENATAL EXPOSURE; PRIORITY JOURNAL; URINALYSIS; DRUG EFFECTS; ENVIRONMENTAL EXPOSURE; GENE EXPRESSION REGULATION; GENETICS; GESTATIONAL AGE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MALE; METABOLISM; MULTIVARIATE ANALYSIS; NEWBORN; PREGNANCY; STATISTICAL MODEL; UNITED STATES; URINE; WATER POLLUTANT;

NEW HAMPSHIRE; UNITED STATES;

ADULT; AQUAPORINS; ARSENIC; BIOLOGICAL MARKERS; BIRTH WEIGHT; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; COHORT STUDIES; FEMALE; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GESTATIONAL AGE; HUMANS; INFANT, NEWBORN; LINEAR MODELS; MALE; MATERNAL EXPOSURE; MULTIVARIATE ANALYSIS; NEW HAMPSHIRE; PHOSPHORIC DIESTER HYDROLASES; PLACENTA; PREGNANCY; WATER POLLUTANTS, CHEMICAL;

EID: 84881175828     PISSN: None     EISSN: 1476069X     Source Type: Journal    
DOI: 10.1186/1476-069X-12-58     Document Type: Article

References (54)

1. NRC, Arsenic in Drinking Water Washington, DC: National Academy Press 1999
2. Some drinking-water disinfectants and contaminants, including arsenic. IARC, IARC monographs on the evaluation of carcinogenic risks to humans. vol. 84 France: IARC Press 2004 37 270
3. Effects of arsenic on maternal and fetal health. Vahter M, Annu Rev Nutr 2009 29 381 399 10.1146/annurev-nutr-080508-141102 19575603
4. Arsenic in drinking water and pregnancy outcomes. Ahmad SA, Sayed MH, Barua S, Khan MH, Faruquee MH, Jalil A, Hadi SA, Talukder HK, Environ Health Perspect 2001 109 629 631 10.1289/ehp.01109629 11445518 (Pubitemid 32998776)
5. Association of arsenic exposure during pregnancy with fetal loss and infant death: a cohort study in Bangladesh. Rahman A, Vahter M, Ekstrom EC, Rahman M, Golam Mustafa AH, Wahed MA, Yunus M, Persson LA, Am J Epidemiol 2007 165 1389 1396 10.1093/aje/kwm025 17351293 (Pubitemid 47234306)
6. Chronic arsenic exposure and adverse pregnancy outcomes in bangladesh. Milton AH, Smith W, Rahman B, Hasan Z, Kulsum U, Dear K, Rakibuddin M, Ali A, Epidemiology 2005 16 82 86 10.1097/01.ede.0000147105.94041.e6 15613949 (Pubitemid 40239281)
7. Arsenic in drinking-water and reproductive health outcomes: a study of participants in the Bangladesh Integrated Nutrition Programme. Kwok RK, Kaufmann RB, Jakariya M, J Health Popul Nutr 2006 24 190 205 17195560 (Pubitemid 46151824)
8. Maternal arsenic exposure associated with low birth weight in Bangladesh. Huyck KL, Kile ML, Mahiuddin G, Quamruzzaman Q, Rahman M, Breton CV, Dobson CB, Frelich J, Hoffman E, Yousuf J, Afroz S, Islam S, Christiani DC, Journal of occupational and environmental medicine/American College of Occupational and Environmental Medicine 2007 49 1097 1104 10.1097/JOM.0b013e3181566ba0 18000415 (Pubitemid 350287342)
9. Teratogenic effects of sodium arsenate in mice. Hood RD, Bishop SL, Arch Environ Health 1972 24 62 65 10.1080/00039896.1972.10666051 5009633
10. Malformations induced by sodium arsenate. Ferm VH, Carpenter SJ, J Reprod Fertil 1968 17 199 201 10.1530/jrf.0.0170199 5748739
11. Arsenic exposure during pregnancy and size at birth: a prospective cohort study in Bangladesh. Rahman A, Vahter M, Smith AH, Nermell B, Yunus M, El Arifeen S, Persson L-A, Ekström E-C, Am J Epidemiol 2009 169 304 312 19037006
12. Arsenic exposure from drinking water and birth weight. Hopenhayn C, Ferreccio C, Browning SR, Huang B, Peralta C, Gibb H, Hertz-Picciotto I, Epidemiology (Cambridge, Mass) 2003 14 593 602 10.1097/01.ede.0000072104.65240. 69 (Pubitemid 40417041)
13. Activation of inflammation/NF-kappaB signaling in infants born to arsenic-exposed mothers. Fry RC, Navasumrit P, Valiathan C, Svensson JP, Hogan BJ, Luo M, Bhattacharya S, Kandjanapa K, Soontararuks S, Nookabkaew S, Mahidol C, Ruchirawat M, Samson LD, PLoS Genet 2007 3 207 10.1371/journal.pgen.0030207 18039032 (Pubitemid 350291578)
14. Arsenic-associated oxidative stress, inflammation, and immune disruption in human placenta and cord blood. Ahmed S, Mahabbat-e Khoda S, Rekha RS, Gardner RM, Ameer SS, Moore S, Ekstrom EC, Vahter M, Raqib R, Environ Health Perspect 2011 119 258 264 20940111
15. Placental 11-beta hydroxysteroid dehydrogenase methylation is associated with newborn growth and a measure of neurobehavioral outcome. Marsit CJ, Maccani MA, Padbury JF, Lester BM, PLoS One 2012 7 33794 10.1371/journal.pone.0033794 22432047
16. In utero exposures, infant growth, and DNA methylation of repetitive elements and developmentally related genes in human placenta. Wilhelm-Benartzi CS, Houseman EA, Maccani MA, Poage GM, Koestler DC, Langevin SM, Gagne LA, Banister CE, Padbury JF, Marsit CJ, Environ Heal Perspect 2012 120 296 302
17. Rice consumption contributes to arsenic exposure in US women. Gilbert-Diamond D, Cottingham KL, Gruber JF, Punshon T, Sayarath V, Gandolfi AJ, Baker ER, Jackson BP, Folt CL, Karagas MR, Proc Natl Acad Sci U S A 2011 108 20656 20660 10.1073/pnas.1109127108 22143778
18. Arsenic, organic foods, and brown rice syrup. Jackson BP, Taylor VF, Karagas MR, Punshon T, Cottingham KL, Environ Health Perspect 2012 120 623 626 10.1289/ehp.1104619 22336149
19. Inorganic arsenic levels in baby rice are of concern. Meharg AA, Sun G, Williams PN, Adomako E, Deacon C, Zhu YG, Feldmann J, Raab A, Environ Pollut 2008 152 746 749 10.1016/j.envpol.2008.01.043 18339463
20. Inorganic arsenic contents in rice-based infant foods from Spain, UK, China and USA. Carbonell-Barrachina AA, Wu X, Ramirez-Gandolfo A, Norton GJ, Burlo F, Deacon C, Meharg AA, Environ Pollut 2012 163 77 83 22325434
21. The use of biomarkers for risk assessment: Reporting from the INTARESE/ENVIRISK Workshop in Prague. Smolders R, Bartonova A, Boogaard PJ, Dusinska M, Koppen G, Merlo F, Sram RJ, Vineis P, Schoeters G, Int J Hyg Environ Health 2010 213 395 400 10.1016/j.ijheh.2010.05.006 20538520
22. Environmental exposure measurement in cancer epidemiology. Wild CP, Mutagenesis 2009 24 117 125 19033256
23. Direct multiplexed measurement of gene expression with color-coded probe pairs. Geiss GK, Bumgarner RE, Birditt B, Dahl T, Dowidar N, Dunaway DL, Fell HP, Ferree S, George RD, Grogan T, James JJ, Maysuria M, Mitton JD, Oliveri P, Osborn JL, Peng T, Ratcliffe AL, Webster PJ, Davidson EH, Hood L, Dimitrov K, Nat Biotechnol 2008 26 317 325 10.1038/nbt1385 18278033 (Pubitemid 351355126)
24. Induction of neoplastic transformation by ectopic expression of human aldo-keto reductase 1C isoforms in NIH3T3 cells. Chien CW, Ho IC, Lee TC, Carcinogenesis 2009 30 1813 1820 10.1093/carcin/bgp195 19696165
25. Gene expression profiling analysis reveals arsenic-induced cell cycle arrest and apoptosis in p53-proficient and p53-deficient cells through differential gene pathways. Yu X, Robinson JF, Gribble E, Hong SW, Sidhu JS, Faustman EM, Toxicol Appl Pharmacol 2008 233 389 403 10.1016/j.taap.2008.09.016 18929588
26. Activation of Hedgehog signaling by the environmental toxicant arsenic may contribute to the etiology of arsenic-induced tumors. Fei DL, Li H, Kozul CD, Black KE, Singh S, Gosse JA, DiRenzo J, Martin KA, Wang B, Hamilton JW, Karagas MR, Robbins DJ, Cancer Res 2010 70 1981 1988 10.1158/0008-5472.CAN-09- 2898 20179202
27. Transcription factor Nrf2 activation by inorganic arsenic in cultured keratinocytes: involvement of hydrogen peroxide. Pi J, Qu W, Reece JM, Kumagai Y, Waalkes MP, Exp Cell Res 2003 290 234 245 10.1016/S0014-4827(03)00341-0 14567983 (Pubitemid 37272168)
28. A phase I study of 5-fluorouracil/leucovorin and arsenic trioxide for patients with refractory/relapsed colorectal carcinoma. Ardalan B, Subbarayan PR, Ramos Y, Gonzalez M, Fernandez A, Mezentsev D, Reis I, Duncan R, Podolsky L, Lee K, Lima M, Ganjei-Azar P, Clin Cancer Res 2010 16 3019 3027 10.1158/1078-0432.CCR-09-2590 20501625
29. Arsenite induces aquaglyceroporin 9 expression in murine livers. Torres-Avila M, Leal-Galicia P, Sanchez-Pena LC, Del Razo LM, Gonsebatt ME, Environ Res 2010 110 443 447 10.1016/j.envres.2009.08.009 19733843
30. Adjusting batch effects in microarray expression data using empirical Bayes methods. Johnson WE, Li C, Rabinovic A, Biostatistics 2007 8 118 127 10.1093/biostatistics/kxj037 16632515 (Pubitemid 44906106)
31. Kline RB, Principles and Practice of Structural Equation Modeling New York: Guilford Press 3 2004
32. Differing birth weight among infants of U.S.-born blacks, African-born blacks, and U.S.-born whites. David RJ, Collins JW, N Engl J Med 1997 337 1209 1214 10.1056/NEJM199710233371706 9337381 (Pubitemid 27454454)
33. Levels of urinary total and speciated arsenic in the US population: National Health and Nutrition Examination Survey 2003-2004. Caldwell KL, Jones RL, Verdon CP, Jarrett JM, Caudill SP, Osterloh JD, J Expo Sci Environ Epidemiol 2009 19 59 68 10.1038/jes.2008.32 18523458
34. Exposure to inorganic arsenic metabolites during early human development. Concha G, Vogler G, Lezcano D, Nermell B, Vahter M, Toxicol Sci 1998 44 185 190 10.1093/toxsci/44.2.185 9742656 (Pubitemid 28415227)
35. Determinants of arsenic metabolism: blood arsenic metabolites, plasma folate, cobalamin, and homocysteine concentrations in maternal-newborn pairs. Hall M, Gamble M, Slavkovich V, Liu X, Levy D, Cheng Z, van Geen A, Yunus M, Rahman M, Pilsner JR, Graziano J, Environ Health Perspect 2007 115 1503 1509 17938743 (Pubitemid 47618094)
36. SLC39A2 and FSIP1 polymorphisms as potential modifiers of arsenic-related bladder cancer. Karagas MR, Andrew AS, Nelson HH, Li Z, Punshon T, Schned A, Marsit CJ, Morris JS, Moore JH, Tyler AL, Gilbert-Diamond D, Guerinot M-L, Kelsey KT, Hum Genet 2012 131 453 461 10.1007/s00439-011-1090-x 21947419
37. Low-level arsenic exposure, AS3MT gene polymorphism and cardiovascular diseases in rural Texas counties. Gong G, O'Bryant SE, Environ Res 2012 113 52 57 22341486
38. Environmental exposure to arsenic, AS3MT polymorphism and prevalence of diabetes in Mexico. Drobná Z, Del Razo LM, García-Vargas GG, Sánchez-Peña LC, Barrera-Hernández A, Stýblo M, Loomis D, Journal of exposure science & environmental epidemiology 2012 23 151 155 23866137
39. Role of aquaporin 9 in cellular accumulation of arsenic and its cytotoxicity in primary mouse hepatocytes. Shinkai Y, Sumi D, Toyama T, Kaji T, Kumagai Y, Toxicol Appl Pharmacol 2009 237 232 236 10.1016/j.taap.2009.03.014 19341753
40. Contribution of aquaporin 9 and multidrug resistance-associated protein 2 to differential sensitivity to arsenite between primary cultured chorion and amnion cells prepared from human fetal membranes. Yoshino Y, Yuan B, Kaise T, Takeichi M, Tanaka S, Hirano T, Kroetz DL, Toyoda H, Toxicol Appl Pharmacol 2011 257 198 208 10.1016/j.taap.2011.09.006 21945491
41. Understanding the role of depression and anxiety on cardiovascular disease risk, using structural equation modeling; the mediating effect of the Mediterranean diet and physical activity: the ATTICA study. Antonogeorgos G, Panagiotakos DB, Pitsavos C, Papageorgiou C, Chrysohoou C, Papadimitriou GN, Stefanadis C, Ann Epidemiol 2012 22 630 637 10.1016/j.annepidem.2012.06.103 22831995
42. A structural equation modeling approach to fatigue-related risk factors for occupational injury. Arlinghaus A, Lombardi DA, Willetts JL, Folkard S, Christiani DC, Am J Epidemiol 2012 176 597 607 10.1093/aje/kws219 22956514
43. Structural equation modeling of the inflammatory response to traffic air pollution. Baja ES, Schwartz JD, Coull BA, Wellenuis GA, Vokonas PS, Suh HH, J Expo Sci Environ Epidemiol 2012 23 268 274 23232970
44. Biochemistry of arsenic detoxification. Rosen BP, FEBS Lett 2002 529 86 92 10.1016/S0014-5793(02)03186-1 12354618 (Pubitemid 35283916)
45. Review: Water channel proteins in the human placenta and fetal membranes. Damiano AE, Placenta 2011 32 Suppl 2 207 211 21208655
46. Molecular characterization of a broad selectivity neutral solute channel. Tsukaguchi H, Shayakul C, Berger UV, Mackenzie B, Devidas S, Guggino WB, van Hoek AN, Hediger MA, J Biol Chem 1998 273 24737 24743 10.1074/jbc.273.38.24737 9733774 (Pubitemid 28454975)
47. Functional and molecular expression of AQP9 channel and UT-A transporter in normal and preeclamptic human placentas. Damiano AE, Zotta E, Ibarra C, Placenta 2006 27 1073 1081 10.1016/j.placenta.2005.11.014 16480766 (Pubitemid 44400514)
48. Biological roles of lysophosphatidic acid signaling through its production by autotaxin. Okudaira S, Yukiura H, Aoki J, Biochimie 2010 92 698 706 10.1016/j.biochi.2010.04.015 20417246
49. Expression of autotaxin, an ectoenzyme that produces lysophosphatidic acid, in human placenta. Iwasawa Y, Fujii T, Nagamatsu T, Kawana K, Okudaira S, Miura S, Matsumoto J, Tomio A, Hyodo H, Yamashita T, Oda K, Kozuma S, Aoki J, Yatomi Y, Taketani Y, Am J Reprod Immunol 2009 62 90 95 10.1111/j.1600-0897. 2009.00715.x 19614625
50. Increased production of bioactive lysophosphatidic acid by serum lysophospholipase D in human pregnancy. Tokumura A, Kanaya Y, Miyake M, Yamano S, Irahara M, Fukuzawa K, Biol Reprod 2002 67 1386 1392 10.1095/biolreprod.102. 004051 12390867 (Pubitemid 35204913)
51. Lysophospholipid signaling in the function and pathology of the reproductive system. Ye X, Hum Reprod Update 2008 14 519 536 10.1093/humupd/dmn023 18562325
52. Mice with transgenic overexpression of lipid phosphate phosphatase-1 display multiple organotypic deficits without alteration in circulating lysophosphatidate level. Yue J, Yokoyama K, Balazs L, Baker DL, Smalley D, Pilquil C, Brindley DN, Tigyi G, Cell Signal 2004 16 385 399 10.1016/j.cellsig.2003.08.012 14687668 (Pubitemid 37542413)
53. Serum autotaxin measurements in pregnant women: application for the differentiation of normal pregnancy and pregnancy-induced hypertension. Masuda A, Fujii T, Iwasawa Y, Nakamura K, Ohkawa R, Igarashi K, Okudaira S, Ikeda H, Kozuma S, Aoki J, Yatomi Y, Clin Chim Acta 2011 412 1944 1950 10.1016/j.cca.2011.06.039 21777571
54. Association between pregnancy induced hypertension and low birth weight; a population based case-control study. Rahman LA, Hairi NN, Salleh N, Asia Pac J Public Health 2008 20 152 158 10.1177/1010539507311553 19124309 (Pubitemid 351441955)